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Summary  
This study investigated the therapeutic effects of connective tissue manipulation (CTM) in 
diabetic foot ulcer (DFU).  A total of 20 participants (10 in CTM group and 10 in conventional 
treatment group (CG)) with DFU underwent the conventional DFU treatment.  In addition, the 
CTM group received CTM twice per week for 6 weeks. The percentage wound area reduction 
(PWAR) and bacterial colonization count (BCC) in log10 colony-forming units (CFU) per ml 
wound fluid was evaluated at baseline and six weeks.  Results showed a significant change in 
PWAR in CTM (p<0.05, t = 3.82, Df = 9, CI L= 0.98 U=3.81) and CG (p<0.05, t = 2.97, Df = 
9,CI L= 0.26 U=1.98). Mean reduction of BCC showed a significant reduction (p<0.05), with 
percentage of BCC reduction higher in CTM group (6.45%) than CG (3.55%).  The findings 
suggest CTM as an effective adjunct therapy for DFU to enhance conventional treatments. 
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Introduction 
Connective tissue manipulation (CTM) is a specialized manipulative therapy pioneered by 
Elisabeth Dicke from Germany in the 1930s (L. A. Holey, 1995a). This manual therapy 
technique utilizes a shear force at connective tissue interfaces which creates a stretch in both 
elastic and viscous components of the tissues (L. A. Holey, 1995b).  CTM has mechanical and 
reflex effects in the peripheral vascular system which causes peripheral vasodilatation and 
increased blood flow to the peripheral areas (L. A. Holey, 1995b). The CTM strokes are usually 
applied by finger tips to the defined zones of the body called connective tissue zones producing 
therapeutic reflex effects on the tissues that shares the same segmental innervations with the 
connective tissue zones (Holey, 2000; L. A. Holey, 1995a; Reed and Held, 1988). Previous 
studies suggest that the peripheral vasodilatation achieved is due to the stimulation of autonomic 
system related cutaneovisceral reflexes and reticular plexus activity (Holey et al., 2011; Reed 
and Held, 1988) combined with regulation of sympathetic-parasympathetic balance (Castro-
Sanchez et al., 2011; L. A. Holey, 1995b; Holey et al., 2011).  
Diabetes is a serious health concern and around 15% of people develop diabetic foot ulcers 
(DFU) (Delmas, 2006; Levin, 1997). The ulcerated diabetic foot may result in ischemia, 
infection, (Levin, 1997) and contribute to 85% of lower limb amputations (Delmas, 2006). 
Therapeutic techniques to prompt revascularization to the ulcerated foot may minimize 
amputation risk and hospitalization (Levin, 1997). In DFU with an underlying pathology of 
deprived peripheral circulation to the wound, the therapeutic effects of CTM due to peripheral 
vasodilatation might be an effective adjunct treatment.  
In DFU, local tissue ischemia causes tissue necrosis and the presence of critical bacterial 
contamination affects the healing status of the wound (Browne et al., 2001; Stojadinovic et al., 
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2008). This higher bacterial burden hinders the healing mechanism by maintaining the 
inflammatory state, thereby delaying the formation of collagen tissue which is essential for the 
healing of the wound (Stojadinovic et al., 2008; Xu et al., 2007).  In addition, impaired 
peripheral blood flow delays the delivery of immune cells and fibroblasts to the ischemic foot, 
further slowing   wound healing (Schramm et al., 2006). If CTM does improve the vascular 
status of the diabetic ischemic foot, then the increased blood flow may improve oxygenation, the 
delivery of antibodies and medication in the affected foot subsequently reducing the bacterial 
count which, in turn should enhance wound healing.   
Whilst the therapeutic effects of CTM have been reported in several studies (Castro-Sanchez et 
al., 2011; Ekici et al., 2009; Reed and Held, 1988), there is a paucity of conclusive evidence to 
support the theoretical basis and the clinical benefits of CTM in diabetic foot ulcer. Therefore the 
aim of this study was to investigate the therapeutic effects of CTM on wound healing in DFU, 
measured by the total bacterial contamination count (BCC) and the percentage wound area 
reduction (PWAR). The hypothesis of this study was that PWAR in DFU would be significantly 
higher if CTM was applied in addition to usual clinical care. 
Materials and Methods 
This was a pilot randomized control trial conducted in the outpatient physiotherapy department 
of a university teaching hospital. A total of 26 subjects were recruited for this study. The 
inclusion criteria includes participants with both fasting blood glucose ( >=110 mg dl-1) (WHO, 
1999) and 2 hours post glucose load ( >=180 mg dl-1)(WHO, 1999), presence of a non-infected 
DFU on the plantar aspect of the foot with Wagner classification (Wagner Jr., 1981; Wagner, 
1987) of grade 1 and 2 (skin ulcer) or Texas grade (Lavery et al., 1996) 1A and below. All the 
participants included are undergoing conventional treatments such as orthotics, antibiotic 
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therapy, drugs therapy and exercise therapy. The exclusion criteria for this study includes 
participants with current haemodialysis, past surgical history of lower limb revascularization, 
participants who are unable to comply a minimum of four treatment sessions continuously, 
bleeding disorders such as hemophilia, sickle cell disease, thrombocytopenia, leukemia, or blood 
dyscariasis, glycosylated hemoglobin (HbA1c) level more than 9% and use of 
immunosuppressive agents.The participants who were accepted for the study were randomized 
into a CTM (intervention) group or usual (control) treatment group.  Pieces of paper were 
numbered and placed into a closed box. The participants were instructed to draw one each and 
those who picked odd numbers were allocated to the CTM group and those with even numbers 
were allocated to the control group. Ethical approval was obtained from the Medical Research 
Secretariat Ethical Committee from a university teaching hospital with (reference NN-010-
2008). Written informed consent was obtained from the participants prior to the participation in 
the study. 
Outcome Measures 
Demographic data was collected from the participants. Measurement of the PWAR and bacterial 
colonization count (BCC) were carried out before and after intervention. Acetate surface area 
tracing for PWAR measurement has been found to be a standard reliable methodand hence was 
used in this study.  The baseline PWAR of the wound surface measurement and the 
corresponding weekly PWAR of the wound surface area of the diabetic foot ulcer was measured 
using a standardized acetate tracing method (Harding, 1995). 
One qualified staff nurse trained in wound surface area measurement with acetate tracing 
measured the circumference of the wound surface in all participantsand was blinded to the 
applied interventions for the study participants.  The margin of the wound was traced on to two 
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layered 0.25 cm2 preprinted sterile acetate tracing, using a black, extra-fine, felt-tipped marking 
pen. The contact layer was discarded and the area of the wound calculated by counting each 
square that is more than half within the border of the wound (Harding, 1995). Finally, the total 
surface area inside each tracing was calculated by multiplying the number of squares with 0.25 
cm as each complete square was equivalent to 0.25 cm2. The participant was positioned in the 
same position (long sitting) at each measurement in order to define the edge of the wound 
accurately. PWAR is the percentage difference in wound surface area (WSA) from baseline to 
end of intervention and is calculated by 
(Baseline WSA – final WSA x 100 = Final WSA) 
BCC at the wound site is a widely used technique to evaluate the healing status of the diabetic 
foot ulcer (Hirsch et al., 2008; Xu et al., 2007).  Therefore, BCC was used to analyze the mean 
percentage reduction of bacterial volume pre and post intervention from the diabetic ulcer site by 
taking a swab from the diabetic wound.  The BCC in log10 colony-forming units (CFU) per ml 
wound fluid from each group was obtained prior to intervention and six weeks after intervention 
to study the potential effects of CTM.  The BCC in log10 was obtained from the wound bed by 
taking a swab based on an established protocol (Levine et al. 1976).  Before harvesting the 
bacterial culture specimen, the wound bed was adequately cleaned with salineto remove excess 
necrotic debris, and gently compressed around wound edges to elicit new drainage. The bacterial 
cultures were obtained from the diabetic foot wound using 1cm2 wide sterile Dacron-tipped 
(DuPont, Wilmington, DE) applicators (swabs). The bacterial swabs were obtained by a trained 
staff nurse by rotating the swab 360 degrees over 1cm2 of the healthiest granulation tissue wound 
tissue while applying gentle pressure to harvest both anaerobes and aerobes. A sufficient 
pressure was applied to the wound to avoid bleeding in the underlying tissue while obtaining the 
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swab.  Care was taken not to spread exudates, pus, eschar, and heavily fibrous tissue into the 
wound bed area. The swabs were immediately coded and placed in 1.0 ml thioglycolate broth 
(transport medium) to prevent contamination and hand-delivered to microbiology laboratory at a 
university teaching hospital where cultures were immediately performed. 
Intervention 
During the 6 weeks of the study, all participants underwent the indicated standard conventional 
DFU treatment which includes foot orthotics, antibiotic therapy, exercise therapy, wound 
dressing and sonotron.  In addition to the conventional treatment, the CTM groups were given 
CTM treatment twice per week. The CTM treatment was rendered twice a week for a period of 6 
weeks over the skin area known as the arterial zone of legs, which is around the sacrum and 
borders of iliac crest for all the participants.  The technique was administered for a duration of 15 
minutes using finger tips by establishing a contact between the middle finger of the therapist’s 
hand and the skin of the patient. The technique was performed by flexion of the distal inter 
phalangeal joint of middle finger to take up ‘slack’ in the superficial tissues on the patients’ skin 
so that the desired strata of tissue is stimulated over the connective tissue zones.  In the first two 
CTM sessions, preparatory techniques such as skin technique and superficial technique were 
given. Preparatory techniques were performed for gentle lifting movements of the layers of skin 
away from the fascial layer to reduce skin tension. The fascial technique which places traction at 
the skin/fascial interface to stimulate the autonomic endings supplying the horizontal circulatory 
plexus to induce autonomic reflex effects was applied for the subsequent sessions. No 
complications or adverse incidents were reported. Two qualified and experienced 
physiotherapists who trained in CTM randomly performed the treatment for all the patients.  The 
therapists who administered the CTM therapy remained blinded to the results of outcome 
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measures.    All the participants received the same protocol of CTM intervention.  The 
participants’ blinding was performed by not disclosing the real benefits of the CTM intervention 
at the time of application of the technique.  Instead the participants were briefed that the back 
massage was given to them in order to relax their mind and well-being.  Thus, the participants 
remained blinded to the actual aim of the study until completing the study and the real benefit of 
the CTM was explained to participants only at the end of the study. 
 
Statistical analysis 
The collected data were analyzed with SPSS version 20. Descriptive analysis was performed to 
evaluate the demographic and clinical characteristics of the subjects. The differences in PWAR 
at the baseline was examined using independent sample t-test between the experimental (CTM 
plus conventional treatment) and control (conventional treatment) groups. Mann-Whitney U test 
were used to analyze the baseline differences of BCC. The result of PWAR after six weeks of 
CTM intervention was analyzed using paired t-test in CTM group and control group.  Wilcoxon 
signed rank test was used to analyze the BCC results between baseline and six weeks in both 
intervention group (A) and control group (B). The significance level was set at p < 0.05 (5%).  
 
Results 
A total of 34 participants were assessed to be eligible for this study, but 26 participants met the 
inclusion criteria and participated in the study. However, only 20 participants completed the full 
6 weeks of the study period and were taken into account for data analysis.  The flow of the study 
participants and drop outs were explained in the study flow chat (Fig.1). Table 1 shows the 
demographic and clinical characteristics of the subjects. All twenty subjects who participated in 
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this study were diagnosed with DM type II and hence there was no DM type I subjects 
participated in this study. 
Regarding PWAR, the analysis showed that the baseline mean surface area was not significantly 
different between the CTM and control groups (p >0.05, see Table 1) The results from Paired t-
test showed a significant difference in relation to the change in PWAR between baseline and six 
weeks in both  the CTM (p<0.05, t = 3.82, Df = 9, CI L= 0.98 U=3.81) and control group 
(p<0.05, t = 2.97, Df = 9, CI L= 0.26 U=1.98) (Table 2).  However, the PWAR was 57% in the 
CTM group and 28% in the control group after 6 weeks of intervention. 
About BCC, there was no significant difference of measures among the participants at the 
baselines between the CTM and control group (p>0.05, see Table 1).  Post six weeks analysis of 
results using Wilcoxon signed rank test showed there was significant reduction of BCC in both 
the CTM group (p<0.05, Z = -2.81, df = 10) and control group (p<0.05, Z = -2.80, df = 10) 
(Table 3).  However, in comparison with the baseline BCC, the post 6 weeks analysis of CTM 
treatment in addition to conventional treatment caused a 6.4% mean reduction of bacterial 
burden on wound surface in CTM group when compared with 3.5% reduction of bacterial burden 
in control group.   
Discussion 
This study is the first reported randomized controlled pilot study on the therapeutic effects of 
CTM on wound healing among patients with DFU. The wound surface area showed significant 
improvement between the initial and final values of PWAR in both the groups.  However, the 
PWAR in the CTM group was 57% compared to 28% in the control group.  This trend suggests 
that CTM can be clinically significant as an adjunct physiotherapeutic intervention to 
conventional DFU management. In the current study, the swab technique was chosen to quantify 
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BCC instead of the tissue biopsy technique.  Although skin/tissue biopsy might be an appropriate 
option, several clinical challenges guided our action to choose swab technique. The process to 
quantify BCC by performing tissue biopsy requires an invasive procedure, is potentially 
traumatic to the patientwhich raises ethical issues, needs expert manipulation, warrants 
specialized equipment and causes increased workload for the microbiology laboratory.  
Furthermore, evidence demonstrates a correlation between surface cultures obtained through 
swab technique and tissue biopsy cultures (Levine et al. 1976, Bowler 2001). Therefore, the 
swab technique was used to quantify BCC as opposed to skin/tissue biopsy technique. 
Regarding BCC, currently, the medical and research communities realize that the static 
progression of chronic wounds may be influenced significantly by the diversity of bacterial 
populations (Dowd et al., 2008; Wolcott et al., 2009). Therefore, the total number of micro 
bacteria existing in the wound was taken into account in this study, instead of particular species 
of the bacteria.  Evidence suggests that most of the acute and chronic wound infections involve 
mixed populations of both aerobic and anaerobic microorganisms. In addition, in view of the 
poly microbial nature of the DFU, it is suggested that the treatment of infection could be based 
on a better understanding on the general microbiology of the wounds in addition to precisely 
define the causative micro organism in wound infection.  Therefore, the bacterial identification 
of the samples to ascertain ecological relationships with wound healing duration was not 
attempted in the current pilot study. While it would be interesting to see the ecological 
relationships to wound healing, it is proposed to be conducted in a future large scale CTM study 
on wound healing. 
After the six week study, there was a significant reduction of bacterial burden in both the CTM 
and the control group between the baseline and six weeks post intervention period.  However the 
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reduction was significantly greater in the CTM group (6.4%) when compared to the control 
group (3.5%). Therefore it could be suggested that CTM in addition to conventional diabetic 
wound care was more effective in diminishing the bacterial growth in DFU subjects than the 
conventional treatment alone. This data finding was consistent with the conceptual explanation 
that a wound environment not conducive to healing can be retarded by high bacterial load itself 
(Xu et al., 2007). The secretion of metalloproteinase and their tissue inhibitors from the bacteria 
disturbs the pattern of inflammatory cytokines and growth factors and therefore are detrimental 
to local tissue healing (Wang et al., 2005). Therefore, an improvement in bacterial colonization 
count is a crucial factor to facilitate the wound healing and hence these effects are clinically 
significant. 
The results obtained in this study can be compared with a previous study that supports the 
therapeutic effects of CTM.  Their study reported improved blood circulation to the lower limbs 
after 15 weeks of CTM among patients with Type II Diabetes (Castro-Sanchez et al., 2011).  It 
further reported on improved oxygen saturation followed by CTM among diabetic patients 
(Castro-Sanchez et al., 2011). Thus, the therapeutic effects obtained in our study could be 
supported by the findings of Castro et al, 2012 as we opine that improved blood circulation and 
oxygen saturation might have facilitated wound healing among our study participants.  It is also 
to be noted that CTM in the current study was applied only for six weeks when compared to the 
fifteen weeks CTM by Castro et al, 2012. Nevertheless, CTM showed evidence of therapeutic 
effectiveness to facilitate healing of diabetic foot ulcer in the current study irrespective of the 
differences in duration of intervention. On the other hand, what is the optimum duration for 
CTM intervention may be of interest to the clinicians and it needs to be explored in future 
studies. 
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The results of this study showed that CTM had therapeutic effects in healing of diabetic ulcer. 
The possible mechanisms of action have been questioned that how these effects have been 
achieved by CTM and by what physiological mechanism. CTM potentially creates traction at the 
skin/fascial interfaces, which are rich in autonomic nerve endings (L. A. Holey, 1995a). It is 
thought to influence the autonomic nervous system through enhanced parasympathetic function, 
causing reflex vasodilatation and increased circulation to the peripheral extremities (Holey, 
2000; Holey et al., 2011). This could be a rationale for our findings as the PWAR is significantly 
reduced in CTM group as compared to the control group.  
There are some limitations to this study. Two therapists carried out the CTM treatment and 
standardization of technique was not monitored, although both had undergone the same training 
in the technique. A small sample size and lack of between group comparisons were other 
limitations in the study.  As it was designed to be a pilot study with a small number of samples, 
subjects, a power analysis and between group comparisons were not performed.  Nevertheless, 
the mean and standard deviation obtained from this pilot study will be used for power analysis 
and sample size calculation in a full larger study in future.  Future trials are required with larger 
sample size across various types of diabetes to validate the clinical effects of CTM on DFU in 
clinical practice. 
Conclusion 
The result from this preliminary study provides support for the use of CTM as an effective 
adjunct therapy for DFU to enhance conventional treatments. Also, the longer term clinical 
effectiveness of these findings needs further investigation. 
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Tables 
 
Table 1. Demographic and clinical characteristics of diabetic subjects 
Characteristic of study subjects 
n=20 
CTM Control Total 
(n) 
% P value 
n % n % 
Gender Male 6 60.0 4 40.0 10 50.0 0.37 
Female 4 40.0 6 60.0 10 50.0 
Diabetes type Type I  0 0 0 0 0 0 NA 
 Type II 10 100 10 100 20 100 
         
  M SD M SD    
Age  55.50 1.96 55.70 1.82   0.63 
Diabetes duration (Yrs)  12.00 1.98 15.10 2.53   0.26 
HbA1c  7.19 0.35 7.71 0.29    
Baseline PWAR  4.15 3.91 4.00 3.28   0.17 
Baseline BCC  3.891 0.266 3.999 0.221   0.44 
M=Mean, SD= Standard deviation, n=number, NA= not applicable,  CTM =connective tissue 
manupulation, PWAR = percentage wound area reduction,  BCC= Bacterial colonization count 
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Table 2. Analysis of PWAR (Cm2) in CTM and Control group 
  
PWAR 
Pre 
Mean ± SD 
Post 
Mean ± SD 
Mean 
Difference 
P value t CI 
Effect 
size 
CTM 
Group 
4.15 ±3.91 1.75±2.49 2.40±1.42 <0.05 3.82  0.98-3.81 0.73 
Control 
Group  
4.00 ± 3.28 2.68±2.67 1.32±0.61 <0.05 2.97  0.26-1.98 0.44 
CTM =Connective tissue manupulation, PWAR = Percentage wound area reduction, CI= 
Confident interval,  SD= standard deviation 
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Table 3. Analysis of BCC (log CFU) in CTM and Control group 
  
BCC 
Pre 
Mean ± SD 
Post 
Mean ± SD 
Mean 
Difference 
P value 
z-
score 
Effect 
size 
CTM Group 
(log CFU) 
3.89±0.26 3.64±0.34 0.25±0.08 p <0.05 -2.81 0.81 
Control Group 
(log CFU) 
3.99±0.22 3.85±0.27 0.14±0.05 p <0.05 -2.80 0.57 
CTM =Connective tissue manupulation, BCC=Bacterial colonization count, SD= standard 
deviation 
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Assessed for eligibility (n= 34) 
Excluded (n= 8) 
 Not meeting inclusion criteria (n= 2) 
 Declined to participate (n= 4) 
 Other reasons (n=2) 
Analysed (n=10)  
 Excluded from analysis (n=3) 
Reasons: 
 Discontinued the intervention in the middle 
(N=2) 
 Did not complete the intervention for 4 
sessions continuously (n=1) 
 
Discontinued the intervention (n= 2) 
Reason:  Felt inconvenient to continue as place of 
living was long distance away from the hospital 
 
CTM Intervention 
 
Allocated to CTM intervention (n= 13) 
 Received allocated intervention (n= 13) 
Lost to follow-up (n=1) 
Reason – Stopped attending therapy with no reason 
(n=1) 
Discontinued intervention (n=2) 
Reason- developed foot infection (n=1), sought native 
treatment (n=1) 
 
Control Group 
 
Allocated to conventional intervention (n= 13) 
 Received allocated intervention (n= 13) 
 
Analysed (n= 10)  
 Excluded from analysis (n=3) 
Reasons: 
 Did not include in analysis as patient 
developed foot infection (n=1) 
 Discontinued from the treatment (n=2) 
Allocation 
Follow-Up 
Randomized (n= 26) 
Enrolment 
Fig 1. Flow chart of the study population throughout the course of the study 
Analysis 
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Legends: 
Table 1. Demographic and clinical characteristics of diabetic subjects 
Table 2. Analysis of PWAR (Cm2) in CTM and Control group 
Table 3. Analysis of BCC (log CFU) in CTM and Control group 
Fig 1. Flow chart of the study population throughout the course of the study 
 
 
